Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:2012:697592.
doi: 10.1155/2012/697592. Epub 2012 Dec 3.

The immune response: targets for the treatment of severe sepsis

Aline M Bernard  1 , Gordon R Bernard
Affiliations

The immune response: targets for the treatment of severe sepsis

Aline M Bernard et al. Int J Inflam. 2012.

Abstract

The clinical process of severe sepsis is characterized by extreme inflammation interlinked with potent stimulation of the coagulation cascade often followed by a state of relative immune paralysis. In this paper, we will review many of the potential therapies directed at various steps along the inflammatory cascade from modulation of inflammatory mediators eliciting the immune response, alteration of the host's immune response in both a stimulatory and depressive manner, and taming the overexuberant coagulation response triggered by the fierce coagulation-inflammation cycle. Finally, we will discuss further opportunities for research to improve our ability to design effective therapies.

PubMed Disclaimer

References

    1. Rice TW, Bernard GR. Therapeutic intervention and targets for sepsis. Annual Review of Medicine. 2005;56:225–248. - PubMed
    1. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. New England Journal of Medicine. 2003;348(2):138–150. - PubMed
    1. Skrupky LP, Kerby PW, Hotchkiss RS. Advances in the management of sepsis and the understanding of key immunologic defects. Anesthesiology. 2011;115(6):1349–1362. - PMC - PubMed
    1. Dellinger RP, Levy MM, Carlet JM. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Critical Care Medicine. 2008;36(1):296–327. - PubMed
    1. Kotsaki A, Giamarellos-Bourboulis EJ. Emerging drugs for the treatment of sepsis. Expert Opinion on Emerging Drugs. 2012;17(3):379–391. - PubMed

LinkOut - more resources